Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate vs propofol for general anesthesia in hidden obesity patients undergoing unilateral biportal endoscopic surgery
ChiCTR2600125190Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in obesity, postoperative pain, postoperative nausea and vomiting (PONV) and 1 more comparing Remimazolam tosylate group with Propofol group (2 arms). Primary endpoint: Extubation time. Planned start May 2026; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
obesitypostoperative painpostoperative nausea and vomiting (PONV)anxiety disorder
Beyond the preview
Go deeper on ChiCTR2600125190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125190.